Andrew Adams
,
Credentials
MD, PhD
Bio
As a transplant surgeon and scientist, Dr. Adams is interested in developing the best therapies and diagnostics for transplant patients, by understanding the fundamental mechanisms of the immune system that give rise to organ rejection. As a graduate student, under the direction of Drs. Chris Larsen and Tom Pearson, Dr. Adams investigated the efficacy of costimulation blockade and helped develop Belatacept, now a clinically available therapy for transplant patients. Belatacept leads to improved survival and kidney function for renal transplant patients. The Adams' Lab has four main areas of investigation (1) costimulation blockade and costimulation independent rejection (2) xenotransplantation (3) transplant diagnostics (4) transplant outcomes.
Research Summary
Dr. Adams research efforts are concentrated on the development of novel strategies and therapeutics to promote transplantation tolerance. He has made important contributions to our understanding concerning the interplay between viral infection, immune memory and the allo-immune response. Dr. Adams is also an internationally recognized expert in large animal models of xenotransplantation (pig-to-non-human primateorgan transplant).
Clinical Summary
Kidney Transplant, Liver Transplant, Pediatric Transplant, Xenotransplant
Education
Fellowships, Residencies, and Visiting Engagements
Honors and Recognition
Professional Memberships
Contact
Address
420 Delaware St SEPWB 11-200
Minneapolis, MN 55455
Administrative Contact
Stephanie Taylor | 612-625-5151 | taylo574@umn.edu